ABIONYX Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.52	3.24	4.1	4.05	7.94
Cash & Short-Term Investments	3.52	3.24	4.1	4.05	7.94
Cash Growth	8.84%	-21.17%	1.43%	-49.01%	-13.32%
Accounts Receivable	0.72	0.99	0.91	1.3	1.33
Other Receivables	0.86	1.3	1.58	1.76	3.29
Receivables	1.59	2.3	2.5	3.05	4.62
Inventory	0.26	0.21	0.22	0.15	0.18
Prepaid Expenses	0.11	0.12	0.07	0.33	0.28
Total Current Assets	5.47	5.86	6.89	7.57	13.01
Property, Plant & Equipment	1.8	1.98	2.22	2.56	3.07
Long-Term Investments	0.08	0.08	0.08	0.08	0.08
Goodwill	5.38	5.38	5.38	5.38	5.38
Other Intangible Assets	0.07	0.08	0.08	0.08	0.08
Other Long-Term Assets	0.27	0.11	0.14	0.12	0.19
Total Assets	13.12	13.54	14.83	15.82	21.83
Accounts Payable	1.52	1.63	1.44	1.85	2.71
Accrued Expenses	2.16	0.75	1.03	1.03	1.51
Short-Term Debt	-	-	0	0	0.17
Current Portion of Long-Term Debt	0.45	0.5	0.5	0.49	0.49
Current Portion of Leases	0.34	0.34	0.31	0.38	0.4
Current Income Taxes Payable	0.14	0.18	-	-	-
Current Unearned Revenue	0.55	0.29	0.59	0.38	0.43
Other Current Liabilities	0	0.01	0.06	0.96	1.04
Total Current Liabilities	5.16	3.71	3.93	5.09	6.75
Long-Term Debt	1.96	0.61	1.1	1.42	1.65
Long-Term Leases	1.05	1.3	1.47	1.73	2.25
Pension & Post-Retirement Benefits	0.43	0.41	0.41	0.42	0.5
Total Liabilities	8.6	6.03	6.91	8.65	11.16
Common Stock	1.78	1.75	1.62	1.42	1.4
Additional Paid-In Capital	6.29	8.61	12.57	8.6	179.21
Retained Earnings	-5.55	-4.38	-3.52	-4.21	-5.82
Treasury Stock	-0.08	-0.25	-0.19	-	-
Comprehensive Income & Other	2.08	1.8	-2.56	1.36	-164.11
Shareholders' Equity	4.51	7.52	7.92	7.17	10.68
Total Liabilities & Equity	13.12	13.54	14.83	15.82	21.83
Total Debt	3.81	2.76	3.39	4.01	4.96
Net Cash (Debt)	-0.28	0.48	0.71	0.03	2.98
Net Cash Growth	-	-33.05%	2063.64%	-98.89%	-67.39%
Net Cash Per Share	-0.01	0.01	0.02	0.00	0.12
Filing Date Shares Outstanding	35.29	34.68	32.21	28.1	27.7
Total Common Shares Outstanding	35.29	34.68	32.21	28.1	27.7
Working Capital	0.3	2.15	2.96	2.48	6.26
Book Value Per Share	0.13	0.22	0.25	0.26	0.39
Tangible Book Value	-0.93	2.06	2.47	1.72	5.22
Tangible Book Value Per Share	-0.03	0.06	0.08	0.06	0.19